Perfect is the enemy of good: Reply to Struikmans et al.
Aznar MC. et al, (2025), Radiother Oncol, 202
Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England.
Jones DA. et al, (2024), Br J Haematol
Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives.
Aznar MC. et al, (2024), Radiother Oncol
Translating Between Radiation Dose and Late Toxicity for Lymphoma Survivors: Implications on Toxicity Counseling and Survivorship
Cutter DJ. and Aleman BMP., (2024), Seminars in Radiation Oncology
Cardiovascular disease incidence rates: a study using routinely collected health data.
Ramroth J. et al, (2023), Cardiooncology, 9
Erratum: 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC).
(2023), Eur Heart J Cardiovasc Imaging, 24
Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.
Jones DA. et al, (2023), Clin Oncol (R Coll Radiol), 35, 301 - 310
Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma.
Geurts YM. et al, (2023), JAMA Oncol, 9, 481 - 489
Cardiac Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review
Bates JE. et al, (2023), International Journal of Radiation Oncology Biology Physics
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma.
Houlihan OA. et al, (2022), Clin Transl Oncol
Guideline for the first-line management of Classical Hodgkin Lymphoma - A British Society for Haematology guideline.
Follows GA. et al, (2022), Br J Haematol, 197, 558 - 572
Colorectal cancer risk following radiotherapy and procarbazine for Hodgkin lymphoma
Shakir R. et al, (2022), RADIOTHERAPY AND ONCOLOGY, 170, S257 - S257
Estimating risk of radiation toxicity for lymphoma patients using pre-chemotherapy PET-CT scans
Shakir R. et al, (2022), RADIOTHERAPY AND ONCOLOGY, 170, S253 - S255
Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.
Ntentas G. et al, (2022), Int J Radiat Oncol Biol Phys, 112, 913 - 925
Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.
Jones DA. et al, (2022), Blood Adv, 6, 909 - 919